|
|
|
|
Hasan A. Falkai P. Wobrock T. Lieberman J., Glenthøj B., Gattaz W.F., Thibaut F., Möller H.J., Mosolov S.N.
|
|
|
International Journal of Psychiatry in Clinical Practice
|
|
|
Schizophrenia is a severe mental disorder and many patients are treated in primary care settings. Apart from the pharmacological management of disease-associated symptoms, the detection and treatment of side effects is of the utmost importance in clinical practice. The purpose of this publication is to offer relevant evidence-based recommendations for the biological treatment of schizophrenia in primary care. This publication is a short and practice-oriented summary of Parts I–III of the World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. The recommendations were developed by the authors and consented by a task force of international experts. Guideline recommendations are based on randomized-controlled trials and supplemented with non-randomized trials and meta-analyses where necessary. Antipsychotics of different chemical classes are the first-line pharmacological treatments for schizophrenia.
|
|
Файл скачали: 182
Просмотров публикации: 332
|
|
|
|
Скачать файл
